Bentad, Lawrence S.

HRN: 21-93-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/26/2022
IVTT
440mg
Q8
PCAP
Waiting Final Action 
09/24/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
09/24/2022
10/01/2022
IVT
2.5 Ml
12 Hrs
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: